Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Hypereosinophilic syndromes].
Groh M, Lefèvre G, Ackermann F, Étienne N, Kahn JE. Groh M, et al. Among authors: kahn je. Rev Prat. 2019 Sep;69(7):767-773. Rev Prat. 2019. PMID: 32233322 French.
Hypereosinophilic syndromes.
Kahn JE, Blétry O, Guillevin L. Kahn JE, et al. Best Pract Res Clin Rheumatol. 2008 Oct;22(5):863-82. doi: 10.1016/j.berh.2008.09.010. Best Pract Res Clin Rheumatol. 2008. PMID: 19028368 Review.
[New insights into hypereosinophilic syndromes].
Bletry O, Kahn JE, Ackermann F, Charles P, Legrand F. Bletry O, et al. Among authors: kahn je. Bull Acad Natl Med. 2010 Mar;194(3):547-59; discussion 559-60. Bull Acad Natl Med. 2010. PMID: 21171248 French.
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
Roufosse FE, Kahn JE, Gleich GJ, Schwartz LB, Singh AD, Rosenwasser LJ, Denburg JA, Ring J, Rothenberg ME, Sheikh J, Haig AE, Mallett SA, Templeton DN, Ortega HG, Klion AD. Roufosse FE, et al. Among authors: kahn je. J Allergy Clin Immunol. 2013 Feb;131(2):461-7.e1-5. doi: 10.1016/j.jaci.2012.07.055. Epub 2012 Oct 4. J Allergy Clin Immunol. 2013. PMID: 23040887 Free PMC article. Clinical Trial.
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
Costedoat-Chalumeau N, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin du LT, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Tanguy ML, Hulot JS, Lechat P, Musset L, Amoura Z, Piette JC; Group PLUS. Costedoat-Chalumeau N, et al. Among authors: kahn je. Ann Rheum Dis. 2013 Nov;72(11):1786-92. doi: 10.1136/annrheumdis-2012-202322. Epub 2012 Nov 10. Ann Rheum Dis. 2013. PMID: 23144449 Clinical Trial.
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.
Legrand F, Renneville A, MacIntyre E, Mastrilli S, Ackermann F, Cayuela JM, Rousselot P, Schmidt-Tanguy A, Fain O, Michel M, de Jaureguiberry JP, Hatron PY, Cony-Makhoul P, Lefranc D, Sène D, Cottin V, Hamidou M, Lidove O, Baruchel A, Dubucquoi S, Bletry O, Preudhomme C, Capron M, Prin L, Kahn JE; French Eosinophil Network. Legrand F, et al. Among authors: kahn je. Medicine (Baltimore). 2013 Sep;92(5):e1-e9. doi: 10.1097/MD.0b013e3182a71eba. Medicine (Baltimore). 2013. PMID: 23982058 Free PMC article.
Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients.
Lefèvre G, Meyer A, Launay D, Machelart I, DeBandt M, Michaud J, Tournadre A, Godmer P, Kahn JE, Behra-Marsac A, Timsit MA, Schleinitz N, Wendling D, Melac-Ducamp S, Boyer P, Peretz A, Lequerré T, Richez C, Stervinou-Wemeau L, Morell-Dubois S, Lambert M, Dubucquoi S, Wallaert B, Benveniste O, Flipo RM, Hatron PY, Sibilia J, Hachulla E, Hervier B; Club Rhumatismes, Inflammation. Lefèvre G, et al. Among authors: kahn je. Rheumatology (Oxford). 2015 May;54(5):927-32. doi: 10.1093/rheumatology/keu404. Epub 2014 Oct 27. Rheumatology (Oxford). 2015. PMID: 25349440
187 results